Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
The Aerospace revenue is pretty dismal considering it's taken what 14 years to get here? However the A330 is quite low production and the MRO market has some 1454 planes in service to address. Once we get on the A320 program the production figures are currently 45 per month and expected to rise to over 60 and there are some 9517 planes in service.
I've said before that in my view the MRO market will be greater than the production market and will be a constant stream of revenue as parts wear and are replaced. I've also said that the turbine blade market can be just as big but has the potential to commercialise much more quickly. The initial gas turbine order was received after some 4 years of Covid delayed testing and EDF have probably been steam testing foe a couple of years already.
So record revenues and possible break-even this year and profits in '22/'23? Good God - we'll be talking divis soon!!!
You have a good point Richie but by its very nature HDD is slow and expensive to grow. Reactors now probably cost over a Mill and take a year to arrive. In addition to that operators need training before the arrival. It says a lot for the Board that in spite of Covid we are in a good place with the prospect of a record year and spare capacity with the exception of a new larger reactor and I've said before that for me the announcement of an order to add another will be important.
Hopefully we will be able to attract a suitable new chair to move us on to a profitable future but the fiscal drag of expansion will be a bit of a challenge. However with our new site there is a clear pathway forward - onwards and upwards is the order of the day I reckon.
My buy also at 7.648 is in red as are all the 5 so far trades - pretty hopeless really!
Thank OG, on the strength of that and the CMD I've just done a small top-up. At circa 8p is this a bargain or is it a bargain???
Well MyLastQuid, Can't answer that - but what a cracking eye opening post. Many thanks - thoughely enjoyed it.
In the past this has had a fluctuating SP and I have been lucky in extracting my original stake and still have (for me) a decent holding. With a stable low cost base and an extremely visible increasing revenue stream, even if (unimaginably) no new revenue streams happen - we will still break into profit from our current deals anyway. What's not to like?
The Swedish promotion event could be important but may necessarily have a long lead time but we have a good story to tell with airbus and Leonardo and the Swedish approach may be more immediate than either of them.
However the webinar on the 31st could well be far more timely and with an equally good story to tell and actually promote the Company and the SP - one can but hope!!
But hey - we're actually getting out there! Wonders will never cease!
Good to see the publicity. Not to sure what regular viewers to SRT's usual webinars will gain but I'm looking forward anyway. Now wouldn't it be good if we announced a new contract before the 18th.....
Hi NotMuch. Thanks for your reply. I looked again at the website with your post in mind and it indeed states that the technology has been acquired. It would appear that you're right and so please accept my apologies and forgive my rudeness! Unfortunately I'm now back to being a little uneasy about the whole thing. As I said before I would have preferred Fox to be in profit before this happened. It now looks more like Compo or bust!! Thanks for the Info.
Hi Laura, there are some strange posters on here some of whom live in the past. If you look at the last 2 years annual accounts and also this years interims you may see a thread that is building on our traditional consulting role but also starting to move into new arears such as clinical trials and commercial collaborations. A couple of years ago they had a brainstorming session with outside consultants and this seemed to give the company a bit of a boost. As always nothing is guaranteed but it is difficult to see anything other than rising revenues and the cost base is pretty tightly controlled. Add a USP into the mix and this could get quite interesting!
Hi not much, If you click the link on bluerill's Friday post you will see the web site says 30 years. This will be a company name change in order to facilitate the new listing. The Company is the same - the name is not.
This is the 3rd appointment in the last 9 months or so. Considering the length of time some appointments can take this shows a definite focus on recruitment. There's much more of a sense of purpose recently. The August appointment of Hayley Close as head of business development was, for me, an important step and she seems to be having the desired effect on our pipeline. Maybe PYC's time is about to come. This could move quite quickly but not as a spike but in a sustained way. Mind you I did quite nicely in the previous spike but now I want sustained growth.
Hi Stas20 & Bakky. in reply to your Sunday posts just a few thoughts on my take on revenue. Over the last 20/25 years I've gambled on the AIM. I buy companies that I view as start-ups in that they have not yet broken even or made a maiden profit. The one stipulation I make is that they have a USP. I've probably done some 70 or so over the years and the majority have either stopped trading or I've pulled out at a loss. However the ones that make it have returned good profits for me well over and above the losses. And I must say it's been a lot of fun with just a few tears!
Vialogy was one I started buying at around 6p in 2008 and followed down to 1.2p in 2013. It was definitely a one trick pony and it's main problem was it's inability to grow revenues. It of course morphed into Premaitha. The 100 to 1 consolidation meant that my initial shares were £1.50 a pop! I invested further in Premaitha as it had a USP for me and if the litigation and debt issues could be resolved I thought it could be a winner. In any of my start-ups the only successful ones are the ones that grow revenues and provided they're reasonably well run profits inevitably seem to follow.
However with the various takeovers we now have a stable of products that are starting to produce revenues - nothing startling as yet but as the Trading Update shows there are improvements. Now we appear to be expanding in the largest healthcare market in the world even if this years revenue is below '21/'22 the margins should be better. I can't actually see any long term issues. Cheers.
Hi Stas20, not looking to start a war but I'm still wondering why the dilution is so important when stacked against other factors. In year'17 (prior to LR) our revenue was 3.1 mill and litigation provision was more than that at 3.4 Mill and debt associated with that was a similar amount. This was resolved in his first year and paved the way for advances in revenue and products.
So if he is responsible for an 84% dilution then put that against revenue increase of 12 times (since '17) and a product increase of 100 times and I wonder why is he so castigated by some PI's?
The II's at the CMD seemed receptive and if 10 professional investment companies are not complaining then I'm taking my lead from them and I'm looking forward to strong future growth.
.. Nobody seems to mention that.
Indeed he is unvrkw, and from the website he is hardly a Captain of Industry but seems to have a reasonable level of experience and ability to be a worthwhile asset. Additionally he could well be an important link in the RTO. Following bluerill's excellent informational posts I'm beginning to be more relaxed about the situation. One of the plus points for me was the appointment of Sir Mark Grant. It's was obviously done with the RTO in mind and I can't see a person of his caliber being involved if the business strategy was flawed, an element of risk? Yes. But with a far greater chance of success. And Compo to boot!!
Hi jonnyCJ, I have to say you ask a good question! The last 4 years have been transformational. The only fly in the ointment is the low SP. Why LR and the BoD are castigated for this is not explained by the complainers. YGEN is only going to go forwards from here.
Many thanks bluerill for the link. I've reread the RNS after visiting Eco's site. I'm hopefully beginning to sort of make sense. Eco is over thirty years in production in two or three continents so it's certainly established and obviously in some of it's upmarket sites particularly India, China and the Middle East you would think an ability to offer bespoke marble would be an advantage. Interestingly the ability to tie down roofs could be a compelling sales pitch in certain US States!!
Obviously we know nothing of the finances of Eco Buildings but there probably not great hence the CLN. However the energy economic advantages of construction and the insulation properties of the finished buildings will become more compelling in the current energy and climate crisis. Many thanks again.
NotmuchinSales. "yet another deal with a recently set up company" Your on the wrong board or of your trolley.
Just re-read the CMD and I reckon this is the best position we've been in since I first bought shares in Vialogy in 2008. I'd prefer to see how this goes now that we've got established in the states. Would be good if the stateside revenue was separate in the full accounts as we know it's doubled, but not from what. The first quarter update should be good.
There's every chance that if the second super-lab comes on stream fairly quickly we will better the '21/'22 revenue anyway.
I was basically encouraged. A lot of info re two of the main products. State side is already into one of the super labs and working on another re NIPT. The Ex5 takeover is paying real service dividends compared to what we paid for it. If the SP does not rise to much this week I will top-up.
Solid growth that looks to be repeated in this current year. I don't think I've ever held in a company before that had such a visible upward trajectory. I just love the largely fixed cost base and the way the the bulk of the revenue increase falls to the bottom line. Now the only question is do we get a maiden divi this financial year or next? Decisions decisions always decisions !!!